EKF Diagnostics HoldingsLSE:EKF +0.75%54 Net Margin % is 0.68% as of Dec. 2025, which is 91% below its 10-year median of 7.36. GuruFocus rates LSE:EKF with a GF Score™ of 54/100 and a GF Value™ of £0.28 (Fairly Valued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, EKF Diagnostics Holdings ranks better than 54.83% on this metric.
The historical rank and industry rank for EKF Diagnostics Holdings's Net Margin % or its related term are showing as below:
LSE:EKF'
s Net Margin % Range Over the Past 10 Years
Min: -15.16 Med: 7.36 Max: 23.76
Current: 4.12
LSE:EKF's Net Margin % is ranked better than 54.83% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs LSE:EKF: 4.12
EKF Diagnostics Holdings (LSE:EKF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
EKF Diagnostics Holdings Net Margin % Related Terms
EKF Diagnostics Holdings Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EKF Diagnostics Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EKF Diagnostics Holdings Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where EKF Diagnostics Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EKF Diagnostics Holdings (LSE:EKF) has a Net Margin % of 0.68% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on EKF Diagnostics Holdings and its competitors. This is 91% below median its historical median of 7.36. According to the industry distribution chart, EKF Diagnostics Holdings ranks #369 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is EKF Diagnostics Holdings' Net Margin % too high?
EKF Diagnostics Holdings' current Net Margin % of 0.68% is 91% below median its 10-year median of 7.36. The Medical Devices & Instruments industry median Net Margin % is 2.09. EKF Diagnostics Holdings' value of 0.68% is 67.5% below this industry median. Based on the distribution chart, EKF Diagnostics Holdings ranks #369 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, EKF Diagnostics Holdings has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does EKF Diagnostics Holdings' Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EKF Diagnostics Holdings ranks #369 out of 817 companies for Net Margin %. This puts EKF Diagnostics Holdings in the upper half of its industry. The industry median Net Margin % is 2.09. EKF Diagnostics Holdings' value of 0.68% is 67.5% below this benchmark. While the company's 10-year median is 7.36 vs. the industry median of 2.09, EKF Diagnostics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EKF Diagnostics Holdings's current Net Margin % of 0.68% is 67.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on EKF Diagnostics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EKF Diagnostics Holdings's current Net Margin % is 0.68%, which is 91% below median its own 10-year median of 7.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EKF Diagnostics Holdings stock overvalued right now?
Based on GuruFocus' analysis, EKF Diagnostics Holdings (LSE:EKF) is currently considered Fairly Valued. The stock's GF Value™ is £0.28, compared to a current price of £0.27 — trading 3.6% below its estimated fair value. The current Net Margin % is 0.68%, which is 91% below median its 10-year median of 7.36 and 67.5% below the Medical Devices & Instruments industry median of 2.09. EKF Diagnostics Holdings' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For EKF Diagnostics Holdings (LSE:EKF), the current Net Margin % is 0.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EKF Diagnostics Holdings (LSE:EKF) Overvalued in 2026?
Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued.
The current stock price of £0.27 is trading 3.6% below its estimated GF Value™ of £0.28.
GuruFocus considers EKF Diagnostics Holdings to be Fairly Valued.
Key valuation signals for LSE:EKF:
Net Margin %: 0.68% (91% below median its 10-year median of 7.36)
GF Value™: £0.28 vs. price of £0.27 (3.6% below fair value)
Industry Position: 67.5% below the Medical Devices & Instruments median (#369 of 817)
No single metric tells the full story. See the LSE:EKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
54GF Score
Get the complete analysis for LSE:EKF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:EKF has been successfully added to your 
